The Patent Finder

Biomics Biotechnologies Co., Ltd.

Also on record
Records under this name other than patents Biomics Biotechnologies Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Biomics Biotechnologies Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,820,942Lipidosome preparation, preparation method and application thereof
Lapsed on the fee record
Ended Nov 21, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 21, 2025USPTO record
US 8,563,710Modified oligonucleotide and its preparation and application
Lapsed on the fee record
Ended Oct 22, 2025 · USPTO record
Lapsed on the fee recordEnded Oct 22, 2025USPTO record
US 9,777,278Long interfering nucleic acid duplexes targeting multiple RNA targets
Lapsed on the fee record
Ended Oct 3, 2025 · USPTO record
Lapsed on the fee recordEnded Oct 3, 2025USPTO record
US 8,217,163Application of highly conserved domain sequences from viral genome as template to design therapeutic slirnas
Formerly held
Lapsed on the fee record
Ended Jul 10, 2024 · USPTO record
Lapsed on the fee recordEnded Jul 10, 2024USPTO record
US 9,284,560Application of highly conserved domain sequences from viral genome as template to design therapeutic sliRNAs
Lapsed on the fee record
Ended Mar 15, 2024 · USPTO record
Lapsed on the fee recordEnded Mar 15, 2024USPTO record
US 10,443,057Multi-targets interfering RNA molecules and their applications
Lapsed on the fee record
Ended Oct 15, 2023 · USPTO record
Lapsed on the fee recordEnded Oct 15, 2023USPTO record
US 9,115,167Multi-targets interfering RNA molecules and their applications
Lapsed on the fee record
Ended Aug 25, 2023 · USPTO record
Lapsed on the fee recordEnded Aug 25, 2023USPTO record
US 9,080,174HBV Treatment
Formerly held
Lapsed on the fee record
Ended Jul 14, 2023 · High confidence
Lapsed on the fee recordEnded Jul 14, 2023High confidence
US 8,846,895Double-stranded RNA molecules with stability in mammalian body fluid, preparation and application thereof
Lapsed on the fee record
Ended Sep 30, 2022 · USPTO record
Lapsed on the fee recordEnded Sep 30, 2022USPTO record
US 9,944,928Construction of pool of interfering nucleic acids covering entire RNA target sequence and related compositions
Lapsed on the fee record
Ended Apr 17, 2022 · USPTO record
Lapsed on the fee recordEnded Apr 17, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited